SpringerLink
Log in

Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2021. J Natl Compr Cancer Netw. 2021;19(3):254–66.

    Article  CAS  Google Scholar 

  2. Peng L, Deng HY, Yang Y. Lobe-specific lymph node dissection for clinical stage IA non-small-cell lung cancer: what do we know? Clin Lung Cancer. 2021. https://doi.org/10.1016/j.cllc.2021.02.007.

    Article  PubMed  Google Scholar 

  3. Handa Y, Tsutani Y, Mimae T, et al. Systematic versus lobe-specific mediastinal lymphadenectomy for hypermetabolic lung cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10020-2.

    Article  PubMed  Google Scholar 

  4. Deng HY, Qin CL, Li G, et al. Can lobe-specific lymph node dissection be an alternative to systematic lymph node dissection in treating early-stage non-small cell lung cancer: a comprehensive systematic review and meta-analysis? J Thorac Dis. 2018;10(5):2857–65.

    Article  Google Scholar 

  5. Deng HY, Zhou J, Wang RL, et al. Lobe-specific lymph node dissection for clinical early-stage (cIA) peripheral non-small cell lung cancer patients: what and how? Ann Surg Oncol. 2020;27(2):472–80.

    Article  Google Scholar 

  6. Feasibility of lobe-specific lymph node dissection in early-stage non-small cell lung cancer: a prospective and randomized controlled study. Chinese Clinical Trial Registry. http://www.chictr.org.cn/showproj.aspx?proj=129575. Accessed 13 July 2021.

  7. Deng HY, Zhou Q. ASO author reflections: lobe-specific lymph node dissection for early-stage non-small cell lung cancer: a long way to go in the era of minimally invasive thoracic surgery. Ann Surg Oncol. 2020;27(2):470–1.

    Article  Google Scholar 

  8. Hishida T, Saji H, Watanabe SI, et al. A randomized phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I–II non-small cell lung cancer (JCOG1413). Jpn J Clin Oncol. 2018;48(2):190–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China

    Han-Yu Deng MD

Authors
  1. Han-Yu Deng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Han-Yu Deng MD.

Ethics declarations

Disclosure

The author declares no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, HY. Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?. Ann Surg Oncol 28 (Suppl 3), 846–847 (2021). https://doi.org/10.1245/s10434-021-10671-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10671-1

Search

Navigation